Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP803197.RAROer_jQ24NDugtCwerOgnwhs7g-uSQpoj4kbr9YFEd8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP803197.RAROer_jQ24NDugtCwerOgnwhs7g-uSQpoj4kbr9YFEd8130_assertion type Assertion NP803197.RAROer_jQ24NDugtCwerOgnwhs7g-uSQpoj4kbr9YFEd8130_head.
- NP803197.RAROer_jQ24NDugtCwerOgnwhs7g-uSQpoj4kbr9YFEd8130_assertion description "[After exposure to such therapies, clones of MET-amplified cancer cells arise within the context of genetically heterogeneous tumors and-exploiting an ample platform of signaling pathways-drive recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803197.RAROer_jQ24NDugtCwerOgnwhs7g-uSQpoj4kbr9YFEd8130_provenance.
- NP803197.RAROer_jQ24NDugtCwerOgnwhs7g-uSQpoj4kbr9YFEd8130_assertion evidence source_evidence_literature NP803197.RAROer_jQ24NDugtCwerOgnwhs7g-uSQpoj4kbr9YFEd8130_provenance.
- NP803197.RAROer_jQ24NDugtCwerOgnwhs7g-uSQpoj4kbr9YFEd8130_assertion SIO_000772 25305631 NP803197.RAROer_jQ24NDugtCwerOgnwhs7g-uSQpoj4kbr9YFEd8130_provenance.
- NP803197.RAROer_jQ24NDugtCwerOgnwhs7g-uSQpoj4kbr9YFEd8130_assertion wasDerivedFrom befree-20150227 NP803197.RAROer_jQ24NDugtCwerOgnwhs7g-uSQpoj4kbr9YFEd8130_provenance.
- NP803197.RAROer_jQ24NDugtCwerOgnwhs7g-uSQpoj4kbr9YFEd8130_assertion wasGeneratedBy ECO_0000203 NP803197.RAROer_jQ24NDugtCwerOgnwhs7g-uSQpoj4kbr9YFEd8130_provenance.